Medication info
Dapagliflozin and Metformin Extended-Release Tablets 10/1000 mg

Dapagliflozin and Metformin Extended-Release Tablets 10/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Bis L-proline›15.63mg / 1 tabletMetformin Hydrochloride›1000mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Yellow to deep yellow, biconvex, oval, film-coated tablet
Packaging
30 tablets/box [6 tablets (Alu-Alu) X 5], 30 tablets/bottle
Approval status
Active

MFDS item code 202108084 · Approved 2021.12.23

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this drug should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This drug is generally administered once daily with the evening meal. The maximum dose of this drug is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior experience of antidiabetic drug therapy and inadequate glycemic control with monotherapy: When used as initial therapy in patients with no prior experience of antidiabetic drug therapy, the recommended starting dose of this drug is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this drug should provide the dose of metformin the patient was taking or an appropriate dose therapeutically close to it. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this drug, the dose of this drug may be started at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. This drug must be swallowed whole and must never be crushed, cut, or chewed. Renal impairment No dose adjustment is required in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2, and without other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, an ingredient of this drug, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this drug is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this drug must be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted via the kidneys and renal function tends to decline in elderly patients, this drug should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar level abnormalities
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication acts by combining dapagliflozin and metformin to help control blood sugar levels in adults with type 2 diabetes. It can be used in conjunction with meal plans and physical exercise for more effective blood sugar management. It is also safe to use in patients with cardiovascular disease or risk factors, but detailed information should be referenced from a specialist's guidance. This medication aids in improving blood sugar management in diabetic patients.

How to take

Adult dose

The dose of this drug should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This drug is generally administered once daily with the evening meal. The maximum dose of this drug is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior experience of antidiabetic drug therapy and inadequate glycemic control with monotherapy: When used as initial therapy in patients with no prior experience of antidiabetic drug therapy, the recommended starting dose of this drug is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this drug should provide the dose of metformin the patient was taking or an appropriate dose therapeutically close to it. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this drug, the dose of this drug may be started at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted as appropriate. When this drug is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. This drug must be swallowed whole and must never be crushed, cut, or chewed. Renal impairment No dose adjustment is required in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2, and without other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, an ingredient of this drug, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this drug is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, this drug must be discontinued immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted via the kidneys and renal function tends to decline in elderly patients, this drug should be used with caution as age increases (see Precautions for Use, 9. Administration to Elderly Patients).

Precautions

This medication is used for the treatment of type 2 diabetes and helps control blood sugar levels. While taking this medication, caution is required as a rare but serious side effect called lactic acidosis may occur. Lactic acidosis is a state where excessive lactic acid accumulates in the body, leading to symptoms such as difficulty breathing, muscle pain, lethargy, abdominal pain, and if any of these symptoms appear, consult a doctor immediately. Additionally, when taken with other diabetes medications such as insulin or sulfonylureas, hypoglycemia can occur, so blood sugar levels should be frequently monitored. Patients with impaired kidney function, dehydration, serious infections, heart problems, or liver dysfunction should not take this medication. Especially, patients with moderate to severe renal impairment should be very cautious or strictly contraindicated from taking this medication. Those scheduled for surgery or undergoing tests using iodinated contrast media should temporarily discontinue this medication before and after the procedure, resuming only after normal kidney function has been restored. Pregnant or breastfeeding women should not take this medication, and its safety and efficacy in children have not been established. This medication should be used with caution in patients at risk for decreased fluid volume or hypotension, especially the elderly or those on diuretics, and blood pressure and kidney function should be periodically monitored. During treatment, genital infections or urinary tract infections may occur, so prompt treatment should be sought if infection symptoms appear. Vitamin B12 levels may decrease, so it is advisable to check vitamin B12 levels with blood tests during prolonged use. Excessive alcohol consumption should be avoided as alcohol can increase the risk of side effects from this medication. While taking this medication, there may be interactions with other drugs, so it is important to inform your doctor or pharmacist of any other medications you are taking. In case of overdose, seek medical attention immediately, as this medication can typically be removed through dialysis. Finally, this medication should be kept out of the reach of children and stored in its original container to maintain quality.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • vulvovaginitis
  • balanitis
  • genital infection
  • urinary tract infection
  • hypoglycemia
  • fluid volume depletion
  • polydipsia
  • diabetic ketoacidosis
Show 83 more
  • dizziness
  • constipation
  • dry mouth
  • low back pain
  • dysuria
  • polyuria
  • nocturia
  • vulvar pruritus
  • genital pruritus
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • elevated blood urea
  • weight loss
  • ketoacidosis
  • urosepsis
  • pyelonephritis
  • acute kidney injury
  • renal dysfunction
  • rash
  • diarrhea
  • nausea
  • vomiting
  • decreased vitamin B12
  • Guillain-Barré syndrome
  • bacterial pneumonia
  • sialadenitis
  • tendinitis
  • chest pain
  • thermal burn
  • wrist fracture
  • gastrointestinal stromal tumor
  • malignant neoplasm of the lung
  • uterine fibroids
  • atrial fibrillation
  • acute cholecystitis
  • epigastric pain
  • dyspepsia
  • abdominal discomfort
  • abdominal pain
  • gastric ulcer
  • irritable bowel syndrome
  • salivary gland mass
  • toothache
  • headache
  • facial paralysis
  • peripheral neuropathy
  • dysesthesia
  • drowsiness
  • tremor
  • nasopharyngitis
  • pharyngitis
  • adenoviral conjunctivitis
  • herpes zoster
  • rhinitis
  • increased alanine aminotransferase
  • increased blood glucose
  • arthralgia
  • myalgia
  • myofascial pain syndrome
  • osteoarthritis
  • osteochondrosis
  • limb pain
  • periartritis
  • tendinitis
  • trigger finger
  • weakness
  • fatigue
  • peripheral edema
  • swelling
  • pain
  • vitamin D deficiency
  • hyperglycemia
  • urethral syndrome
  • cough
  • hyperventilation
  • skin abrasion
  • itching
  • palpitations
  • insomnia
  • type 2a hyperlipidemia
  • sensorineural hearing loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Proper storage ensures the safety and efficacy of the medication.

Appearance and packaging

Appearance

Yellow to deep yellow, biconvex, oval, film-coated tablet

Package unit

30 tablets/box [6 tablets (Alu-Alu) X 5], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.